Expert Perspectives: Advances in the Management of Acute Migraine

EP. 1: Acute Migraine Management: Overview and Unmet Needs

ByAmaal J. Starling, MD,Wade M. Cooper, DO

January 18th 2021

EP. 2: Goals of and Recommended Approach for Acute Treatment

ByAmaal J. Starling, MD,Wade M. Cooper, DO

January 18th 2021

EP. 3: Acute Migraine Treatment: Pain Freedom and Guidelines

ByAmaal J. Starling, MD,Wade M. Cooper, DO

January 18th 2021

EP. 4: Therapy Assessment: Pain Relief & Onset Monitorization

ByAmaal J. Starling, MD,Wade M. Cooper, DO

January 18th 2021

EP. 5: The Importance of Patient Communication

ByAmaal J. Starling, MD,Wade M. Cooper, DO

January 18th 2021

EP. 6: Recent Approvals for Acute Migraine

ByAmaal J. Starling, MD,Wade M. Cooper, DO

January 18th 2021

EP. 7: The Significance of 5-HT1F Agonist Approval

ByAmaal J. Starling, MD,Wade M. Cooper, DO

January 18th 2021

EP. 8: 5-HT1F Agonist Toxicity Profile and Role in Paradigm

ByAmaal J. Starling, MD,Wade M. Cooper, DO

January 18th 2021

EP. 9: CGRP Receptor Agonists: Safety and Efficacy

ByAmaal J. Starling, MD,Wade M. Cooper, DO

January 18th 2021

EP. 10: The Role of Developing Agents in Acute Migraine Paradigm

ByAmaal J. Starling, MD,Wade M. Cooper, DO

January 18th 2021

Trending on NeurologyLive

Del-Zota Reverses Duchenne Disease Progression in 1-Year Trial Update

EMA Approves Semaglutide as First GLP-1 RA for Cardiovascular, Stroke-Related Benefits

Evolving Responsibilities of Vice Chairs in Neurology Leadership: Mud Alvi, MD

Current Challenges and New Opportunities Ahead for Women in Neurology

Managing Dyskinesia Through Continuous Infusion Therapy

© 2025 MJH Life Sciences^®

All rights reserved.